Corline Biomedical AB Logo

Corline Biomedical AB

Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.

CLBIO | ST

Overview

Corporate Details

ISIN(s):
SE0006887451
LEI:
549300KYLOA3DVEPZ069
Country:
Sweden
Address:
Lefflersgatan 5, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Corline Biomedical AB is a life-science company that develops, manufactures, and markets proprietary heparin-based solutions. It specializes in antithrombotic and anti-inflammatory surface coatings for the medical device industry and applications in regenerative medicine. The company's core offering is the Corline Heparin Surface (CHS™), a unique macro-molecular heparin technology designed to improve the biocompatibility of medical devices and manage immune responses. Its product portfolio also includes drug candidates Renaparin® and Cytoparin™, which are being developed to improve outcomes in kidney transplantation and cell therapies. Corline's technology aims to address unmet clinical needs by making foreign materials and therapeutic cells better tolerated by the patient's body.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Corline Biomedical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Corline Biomedical AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Corline Biomedical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden NNH
Newron Pharmaceuticals S.p.A. Logo
Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.
Italy NWRN
NextCell Pharma AB Logo
Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.
Sweden NXTCL
NGeneBio Co., Ltd. Logo
Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.
South Korea 354200
NIBEC CO., LTD. Logo
Biotech CDMO creating regenerative products with peptide and biomaterial technologies.
South Korea 138610
NIPPON CHEMIPHAR CO., LTD. Logo
Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.
Japan 4539
Nippon Shinyaku Co.,Ltd. Logo
Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.
Japan 4516
NKMAX Co., Ltd. Logo
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea 182400
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.